Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | CRBP |
---|---|---|
09:32 ET | 14146 | 18.69 |
09:34 ET | 30818 | 18.6001 |
09:36 ET | 17951 | 18.4 |
09:38 ET | 32329 | 18.6 |
09:39 ET | 22869 | 18.6682 |
09:41 ET | 20429 | 18.6 |
09:43 ET | 8744 | 18.565 |
09:45 ET | 10594 | 18.69 |
09:48 ET | 4400 | 18.77 |
09:50 ET | 14294 | 18.89 |
09:52 ET | 5055 | 18.7594 |
09:54 ET | 5118 | 18.6148 |
09:56 ET | 15274 | 18.6565 |
09:57 ET | 9174 | 18.57 |
09:59 ET | 7717 | 18.67 |
10:01 ET | 1782 | 18.532 |
10:03 ET | 2188 | 18.55 |
10:06 ET | 3185 | 18.46 |
10:08 ET | 5142 | 18.57 |
10:10 ET | 507 | 18.53 |
10:12 ET | 2524 | 18.4917 |
10:14 ET | 11557 | 18.485 |
10:15 ET | 2696 | 18.5 |
10:17 ET | 2854 | 18.59 |
10:19 ET | 990 | 18.59 |
10:21 ET | 1914 | 18.65 |
10:24 ET | 9700 | 18.72 |
10:26 ET | 12274 | 18.75 |
10:28 ET | 1621 | 18.81 |
10:30 ET | 2210 | 18.76 |
10:32 ET | 14430 | 18.62 |
10:33 ET | 2982 | 18.7603 |
10:35 ET | 200 | 18.685 |
10:37 ET | 500 | 18.66 |
10:39 ET | 4800 | 18.641 |
10:42 ET | 11375 | 18.6 |
10:44 ET | 3419 | 18.63 |
10:46 ET | 864 | 18.66 |
10:48 ET | 3116 | 18.86 |
10:50 ET | 11734 | 18.8828 |
10:51 ET | 20557 | 18.815 |
10:53 ET | 900 | 18.83 |
10:55 ET | 900 | 18.85 |
10:57 ET | 500 | 18.785 |
11:00 ET | 4654 | 18.795 |
11:04 ET | 2127 | 18.7317 |
11:06 ET | 1409 | 18.79 |
11:08 ET | 1100 | 18.79 |
11:09 ET | 5803 | 19 |
11:11 ET | 2032 | 19.05 |
11:13 ET | 2393 | 19.23 |
11:15 ET | 3732 | 19.195 |
11:18 ET | 4740 | 19.3198 |
11:20 ET | 2463 | 19.26 |
11:22 ET | 4087 | 19.29 |
11:24 ET | 938 | 19.285 |
11:26 ET | 15159 | 19.43 |
11:27 ET | 3050 | 19.41 |
11:29 ET | 6949 | 19.3888 |
11:31 ET | 3065 | 19.2583 |
11:33 ET | 1800 | 19.17 |
11:36 ET | 8868 | 18.82 |
11:38 ET | 11750 | 18.75 |
11:40 ET | 1603 | 18.8099 |
11:42 ET | 5275 | 18.838284 |
11:44 ET | 1616 | 18.83 |
11:45 ET | 259 | 18.8992 |
11:47 ET | 1650 | 18.805 |
11:49 ET | 3362 | 18.67 |
11:51 ET | 2140 | 18.69 |
11:54 ET | 300 | 18.725 |
11:56 ET | 4582 | 18.8 |
11:58 ET | 4490 | 18.65 |
12:00 ET | 20967 | 18.495 |
12:02 ET | 3301 | 18.52 |
12:03 ET | 20620 | 18.56 |
12:05 ET | 2533 | 18.65 |
12:07 ET | 300 | 18.625 |
12:09 ET | 1966 | 18.6262 |
12:12 ET | 14660 | 18.5261 |
12:14 ET | 386 | 18.585 |
12:16 ET | 1800 | 18.49 |
12:18 ET | 3700 | 18.56 |
12:20 ET | 325 | 18.57 |
12:23 ET | 3624 | 18.56 |
12:25 ET | 800 | 18.52 |
12:27 ET | 2943 | 18.5 |
12:30 ET | 2620 | 18.51 |
12:32 ET | 2949 | 18.57 |
12:34 ET | 2279 | 18.59 |
12:36 ET | 1030 | 18.5988 |
12:38 ET | 100 | 18.5997 |
12:39 ET | 2300 | 18.5773 |
12:41 ET | 2650 | 18.53 |
12:45 ET | 1400 | 18.51 |
12:48 ET | 5450 | 18.55 |
12:50 ET | 1425 | 18.545 |
12:52 ET | 663 | 18.5147 |
12:54 ET | 750 | 18.6 |
12:56 ET | 2250 | 18.5651 |
12:57 ET | 2079 | 18.5 |
12:59 ET | 1200 | 18.555 |
01:01 ET | 1681 | 18.52 |
01:03 ET | 100 | 18.535 |
01:06 ET | 2330 | 18.55 |
01:08 ET | 1195 | 18.55 |
01:12 ET | 6097 | 18.505 |
01:14 ET | 824 | 18.51 |
01:15 ET | 13864 | 18.55 |
01:17 ET | 3919 | 18.495 |
01:19 ET | 1300 | 18.57 |
01:24 ET | 197 | 18.5699 |
01:28 ET | 5138 | 18.575 |
01:30 ET | 641 | 18.55 |
01:32 ET | 1200 | 18.57 |
01:33 ET | 1400 | 18.575 |
01:35 ET | 1624 | 18.665 |
01:37 ET | 1500 | 18.6899 |
01:39 ET | 123 | 18.655 |
01:42 ET | 650 | 18.7 |
01:44 ET | 3044 | 18.68 |
01:46 ET | 1812 | 18.71 |
01:48 ET | 1100 | 18.735 |
01:50 ET | 808 | 18.6503 |
01:51 ET | 1876 | 18.695 |
01:55 ET | 1462 | 18.735 |
01:57 ET | 1000 | 18.735 |
02:00 ET | 2455 | 18.68 |
02:02 ET | 1176 | 18.6 |
02:04 ET | 233 | 18.63 |
02:06 ET | 920 | 18.67 |
02:08 ET | 700 | 18.7 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Corbus Pharmaceuticals Holdings Inc | 228.7M | -3.2x | --- |
Gossamer Bio Inc | 226.2M | -2.5x | --- |
Immutep Ltd | 341.1M | -9.7x | --- |
Acrivon Therapeutics Inc | 223.9M | -2.6x | --- |
Candel Therapeutics Inc | 222.7M | -4.1x | --- |
Compass Therapeutics Inc. | 218.8M | -4.6x | --- |
Corbus Pharmaceuticals Holdings, Inc. is a precision oncology company with a diversified portfolio. The Company's pipeline is comprised of two experimental drugs targeting solid tumors: CRB-701, which is an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload and CRB-601, which is an anti-integrin monoclonal antibody that blocks the activation of TGFβ expressed on cancer cells. Its pipeline also includes CRB-913, which is a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. It has in-licensed the intellectual property for CRB-601 from Dr. Stephen Nishimura's laboratory at the University of California, San Francisco. The Company does not own or operate manufacturing facilities and relies on third-party contract manufacturing organizations or licensing partners to supply it with drugs for pre-clinical and clinical studies and commercial activities.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $228.7M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 12.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.57 |
EPS | $-5.82 |
Book Value | $-1.56 |
P/E Ratio | -3.2x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.